A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects
Authors
Keywords
RGD, Tumor homing, Apoptosis
Journal
APOPTOSIS
Volume 20, Issue 10, Pages 1307-1320
Publisher
Springer Nature
Online
2015-08-17
DOI
10.1007/s10495-015-1151-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates
- (2014) Ke Wang et al. BIOMATERIALS
- Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase
- (2013) Alessandra Rossi et al. APOPTOSIS
- Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
- (2013) Matthew Brentnall et al. BMC CELL BIOLOGY
- A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
- (2013) Xingzhen Lao et al. PLoS One
- Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond
- (2012) Riccardo Danielli et al. Annals of the New York Academy of Sciences
- Thymosin α1 and cancer: action on immune effector and tumor target cells
- (2012) Enrico Garaci et al. Annals of the New York Academy of Sciences
- Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
- (2012) Matthew W. Parker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NMR structure of human thymosin alpha-1
- (2011) Miguel-Angel Elizondo-Riojas et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The C terminus of talin links integrins to cell cycle progression
- (2011) Pengbo Wang et al. JOURNAL OF CELL BIOLOGY
- Neuropilin-1 expression in cancer and development
- (2011) Adrian M Jubb et al. JOURNAL OF PATHOLOGY
- A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke
- (2011) Jon N Marsh et al. Nanomedicine
- Transtumoral targeting enabled by a novel neuropilin-binding peptide
- (2011) L Roth et al. ONCOGENE
- Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions
- (2011) Nadejda Vintonenko et al. Cell Adhesion & Migration
- Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
- (2010) Ashley Jarvis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- From lab to bedside: emerging clinical applications of thymosin α1
- (2009) Allan L Goldstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An RGD-Modified Endostatin-Derived Synthetic Peptide Shows Antitumor Activityin Vivo
- (2008) Han-Mei Xu et al. BIOCONJUGATE CHEMISTRY
- TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
- (2008) W. Yang et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now